v3.26.1
Stockholders' Equity - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended
Jun. 05, 2025
Sep. 27, 2022
Apr. 06, 2022
Oct. 18, 2021
Feb. 28, 2026
Nov. 30, 2025
May 31, 2025
Feb. 29, 2024
Mar. 31, 2026
Dec. 31, 2025
Stockholders Equity [Line Items]                    
Common Stock, Shares, Outstanding                 128,411,048 128,306,056
Share based compensation options grants in the period                 3,176,250  
Performance-Based Vesting Stock Options [Member]                    
Stockholders Equity [Line Items]                    
Share based compensation options grants in the period         710,500     832,250    
Share-based compensation options vested (in shares)             642,160      
Private Placement [Member] | Pre-funded Warrants [Member]                    
Stockholders Equity [Line Items]                    
Common Stock, Shares, Outstanding                 12,531,332  
Private Placement [Member] | New Enterprise Associates 16, L.P [Member]                    
Stockholders Equity [Line Items]                    
Warrants to purchase aggregate shares of common stock       3,703,704            
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock [Member]                    
Stockholders Equity [Line Items]                    
Sale of stock during the period       1,851,852            
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock and Accompanying Common Stock Warrants [Member]                    
Stockholders Equity [Line Items]                    
Common stock warrants exercise price and expiration date description                 The accompanying common stock warrants have an exercise price of $1.37 per share and became exercisable immediately upon issuance. Of the accompanying common stock warrants, warrants to purchase an aggregate of 1,851,852 shares of the Company’s common stock were scheduled to expire on April 18, 2025, and warrants to purchase an aggregate of 1,851,852 shares of the Company’s common stock will expire on October 18, 2028. On April 17, 2025, NEA exercised all of the warrants that would have expired on April 18, 2025. None of the accompanying common stock warrants issued to NEA in the private placement that expire on October 18, 2028 have been exercised.  
Combined price of each shares       $ 1.62            
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs       $ 3.0            
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock Warrants                    
Stockholders Equity [Line Items]                    
Warrants to purchase aggregate shares of common stock       1,851,852            
Exercise price per share of warrants       $ 1.37            
Warrants expiration date       Apr. 18, 2025            
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Warrants [Member]                    
Stockholders Equity [Line Items]                    
Warrants to purchase aggregate shares of common stock       1,851,852            
Warrants expiration date       Oct. 18, 2028            
Private Placement [Member] | Securities Purchase Agreement [Member] | Common Stock [Member]                    
Stockholders Equity [Line Items]                    
Sale of stock during the period     4,580,526              
Combined price of each shares     $ 1.90              
Private Placement [Member] | Securities Purchase Agreement [Member] | Pre-funded Warrants [Member]                    
Stockholders Equity [Line Items]                    
Combined price of each shares     $ 1.899              
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs     $ 55.0              
Exercise price per share of warrants     $ 0.001              
September 2022 Offering [Member] | Pre-funded Warrants [Member]                    
Stockholders Equity [Line Items]                    
Common Stock, Shares, Outstanding                 4,717,616  
September 2022 Offering [Member] | Underwriting Agreement [Member]                    
Stockholders Equity [Line Items]                    
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs   $ 58.1                
Warrants initial closing date   Sep. 27, 2022                
September 2022 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                    
Stockholders Equity [Line Items]                    
Sale of stock during the period   14,252,670                
Combined price of each shares   $ 1.93                
Exercise price per share of warrants   $ 0.001                
September 2022 Offering [Member] | Underwriting Agreement [Member] | Pre-funded Warrants [Member]                    
Stockholders Equity [Line Items]                    
Warrants to purchase aggregate shares of common stock   14,247,330                
Combined price of each shares   $ 1.929                
Options to purchase additional shares   1,600,428                
June 2025 Offering [Member] | Underwriting Agreement [Member]                    
Stockholders Equity [Line Items]                    
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs $ 115.1                  
June 2025 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                    
Stockholders Equity [Line Items]                    
Sale of stock during the period 17,400,000                  
Combined price of each shares $ 5.75                  
Maximum [Member] | Private Placement [Member] | Securities Purchase Agreement [Member] | Pre-funded Warrants [Member]                    
Stockholders Equity [Line Items]                    
Warrants to purchase aggregate shares of common stock     24,379,673              
Maximum [Member] | September 2022 Offering [Member] | Underwriting Agreement [Member] | Pre-funded Warrants [Member]                    
Stockholders Equity [Line Items]                    
Warrants to purchase aggregate shares of common stock   4,275,000                
Maximum [Member] | June 2025 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                    
Stockholders Equity [Line Items]                    
Warrants to purchase aggregate shares of common stock 2,610,000                  
Common Stock Purchase Agreement [Member]                    
Stockholders Equity [Line Items]                    
Aggregate offering price of common stock which may issue and sell under agreement           $ 200.0        
Sale of stock during the period                 0